Position in VTRS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$622,638
+$40,128 QoQ
Shares Held
39,209
-9.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#374
of 1,016 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Farther Finance Advisors, LLC holds $5,620,756 across 55 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,312 | $710,880 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
20,420 | $707,961 | |
| 3 | ZTS |
Zoetis Inc.
|
8,686 | $624,175 | |
| 4 | VTRS |
Viatris Inc
This page
|
39,209 | $622,638 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,418 | $488,481 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
13,324 | $482,328 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
2,503 | $421,855 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
21,332 | $341,951 |
All Filings in VTRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $622,638 | 39,209 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $582,510 | 43,117 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $285,366 | 22,921 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $151,163 | 15,269 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $126,341 | 14,148 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $96,289 | 11,055 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $137,385 | 11,035 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $98,928 | 8,521 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $82,403 | 7,752 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $90,087 | 7,545 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $67,514 | 6,234 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $49,793 | 5,050 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,468 | 4,556 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $36,046 | 3,747 | Shares | Sole | 2024-05-14 | |
| 2022-12-31 | $28,726 | 2,581 | Shares | Sole | 2023-09-12 | |
| No filing history on record for this holder in this stock. | ||||||